A. Articles Published in International Peer-reviewed Journals 
1)    Afsar CU, Karabulut M, Karabulut S, Ozal ST, Cikot M, Serilmez M, Tas F. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Biomolecules 2018; 8(4). pii: E169. doi: 10.3390/biom8040169
2)    Afsar CU, Uysal P. HIF-1α Levels in patients receiving chemoradiotherapy for locally advanced non-small cell lung carcinoma. Rev Assoc Med Bras (1992) 2019; 65(10): 1295-99.
3)    Cigdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Murat Serilmez, Faruk Tas. Circulating Interleukin-18 (Il-18) Is A Predictor of Response To Gemcitabine Based Chemotherapy in Patients with Pancreatic Adenocarcinoma. J Infect Chemother 2017; 23(4): 196-200.
4)    Cigdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Murat Serilmez, Faruk Tas. Circulating Macrophage Inflamatuar Protein-1 Alfa (MCP-1/CCL-2) As A Potential Biomarker for The Diagnosis of Patients with Pancreatic Adenocarcinoma. Acta Medica Mediterranea 2017; 33: 501-7.
5)    Afsar CU, Afsar S. SARS-CoV-2 (COVID-19): Interferon-epsilon may be responsible of decreased mortality in females. J Reprod Immunol 2020; 141: 103154.
6)    Usul Afsar C. 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Cruciality of Furin and relevance with cancer. Med Hypotheses 2020; 140: 109770.
7)    Afşar CU, Kara IO, Kozat BK, Demiryürek H, Duman BB, Doran F. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: Four cases of rare tumors and a review of the literature. Crit Rev Oncol Hematol 2013; 86(2): 191-9.
8)    Afsar CU, Uzun H, Yurdakul S, Muderrisoglu C, Ergüney M, Demir B, Aslan A, Aral H, Ozyazgan S. Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome. Clin Invest Med 2012; 35(4): E206-15.
9)    Usul Afşar C, Paydaş S, Günaldı M, Bozkurt Duman B, Erçolak V, Zorludemir S, Açıkalın A. Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: curious lymphocyte/neutrophil fluctuations. Turk J Haematol 2013; 30(4): 413-5. 
10)    Afsar CU, Gunaldi M, Kum P, Sahin B, Erkisi M, Kara IO, Paydas S, Duman BB, Ercolak V, Karaca F, Uyeturk U, Guner SI. Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev 2014; 15(21): 9143-6.
11)    Usul Afsar C, Sahin B, Gunaldi M, Kılıc Bagir E, Gumurdulu D, Burgut R, Erkisi M, Kara IO, Paydas S, Karaca F, Ercolak V. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung. Int J Clin Exp Pathol. 2015; 8(9): 9760-71. 
12)    Cigdem Usul Afsar, Feryal Karaca, Meral Günaldı, İsmail Oğuz Kara, Melek Erkişi, Berksoy Şahin, Berna Bozkurt Duman, Semra Paydaş, Vehbi Ercolak. The effect of chemoradiotherapy on survival in locally advanced unresectable non-small cell lung cancer patients: experience from the southeast region of Turkey. Acta Medica Mediterranea 2015, 31: 883-8.
13)    Cigdem Usul Afsar, Semra Paydas. Using Pazopanib and Radiotherapy to Treat Metastatic Renal Cell Carcinoma with Acrometastases. International Journal of Medical and Pharmaceutical Case Reports 2015; 4(2): 50-3. 
14)    Afsar CU, Gunaldı M, Okuturlar Y, Gedikbası A, Tiken EE, Kahraman S, Karaca F, Ercolak V, Karabulut M. Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. Int J Clin Exp Med 2015; 8(11): 21599-604. eCollection 2015.

15)    Yardimci AH, Sel I, Bektas CT, Yarikkaya E, Dursun N, Bektas H, Afsar CU, Gursu RU, Yardimci VH, Ertas E, Kilickesmez O. Computed tomography texture analysis in patients with gastric cancer: a quantitative imaging biomarker for preoperative evaluation before neoadjuvant chemotherapy treatment. Jpn J Radiol 2020 Mar 5. doi: 10.1007/s11604-020-00936-2. [Epub ahead of print]

16)    Duman BB, Paydas S, Tetiker T, Gunaldı M, Afsar CU, Erçolak V, Haksöyler V, Dilli MŞ. Capecitabine-induced hypertriglyceridemia and hyperglycemia: two cases. Pharmacology 2012; 90(3-4): 212-5. 

17)    Duman BB, Gunaldi M, Ercolak V, Afsar CU, Sahin B, Erkisi IM, Kara O, Paydas S, Gönlüsen G, Sertdemir Y. Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. Asian Pac J Cancer Prev 2012; 13(8): 4125-8. 

18)    Duman BB, Afşar ÇU, Günaldi M, Sahin B, Kara IO, Erkisi M, Erçolak V. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pac J Cancer Prev 2012; 13(8): 4119-23. 

19)    Kara IO, Duman BB, Afsar CU. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry. J BUON 2013; 18(2): 442-7.

20)    Günaldi M, Paydas S, Afsar CU, Doran F. Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Med J 2013; 54(11): e233-5.

21)    Günaldı M, Paydaş S, Usul Afşar C, Bozkurt Duman B, Erçolak V, Haksöyler V. Carbamazepine and multiple myeloma: possible interaction. Turk J Haematol 2013; 30(1): 83-4. 

22)    Gunaldi M, Kara IO, Duman BB, Afsar CU, Ergin M, Avci A. A new approach to the treatment of metastatic paraganglioma: sorafenib. Cancer Res Treat 2014; 46(4): 411-4.

23)    Ercolak V, Paydas S, Ergin M, Ates BT, Duman BB, Gunaldi M, Afsar CU. Abdominal actinomycosis with multiple myeloma: A case report. Oncol Lett 2014; 8(4): 1876-8.

24)    Günaldı M, Erkisi M, Afşar CU, Erçolak V, Paydas S, Kara IO, Sahin B, Gulec UK, Secilmis A. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment. Pharmacology 2014; 94(3-4): 183-9.

25)    Sözütek D, Yanık S, Akkoca AN, Sözütek A, Ozdemir ZT, Avşar CU, Günaldı M, Sahin B, Doron F. Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. Int J Clin Exp Med. 2014; 7(7): 1914-22. eCollection 2014.

26)    Karaca F, Usul Afşar C, Erkurt E, Arslantaş HS, Calış E, Totan Ateş B, Bağır E, Ergin M, Paydaş S. The Role of Radiotherapy Among the Therapeutic Options for Castleman's Disease. Turk J Haematol 2014; 31(2): 197-8

27)    Erçolak V, Kara O, Günaldı M, Usul Afşar C, Bozkurt Duman B, Açıkalın A, Ergin M, Erdoğan S. Bilateral primary adrenal non-hodgkin lymphoma. Turk J Haematol 2014; 31(2): 205-6.

28)    Feryal Karaca, Çiğdem Usul Afşar, Erkut Erkurt, Candaş Tunalı, Hasan Suat Arslantaş, Çiğdem Kocabaş. Primary Spinal Glioblastoma Multiforme: A Case Report and Review of The Literature. Journal of Neurological Sciences (Turkish) 2014; 31 (2): 366-76.

29)    Feryal Karaca, Çiğdem Usul Afşar, Meral Günaldı and Berksoy Şahin. Neuroblastoma in the Adult: Which Therapy is Effective? Clinic Pharmacol Biopharmaceut 2014; 3: 119. doi: 10.4172/2167-065X.1000119.

30)    Vehbi Ercolak, İsmail Oğuz Kara, Berna Bozkurt Duman, Meral Günaldı, Çiğdem Usul Afşar, Şeyda Erdoğan, Berna Totan Ateş. A case report of adult Wilms’ tumour. Contemp Oncol (Pozn) 2014; 18. DOI (digital object identifier): 10.5114/wo.2014.40616.

31)    Meral Günaldı, Berna Bozkurt Duman, Vehbi Erçolak, Çiğdem Usul Afşar, Melek Erkişi, Semra Paydaş, İsmail Oğuz Kara, Berksoy Şahin, Gülfiliz Gönlüşen. Retrospective Analysis of 119 Osteosarcomas in a Single Centre Experience. Journal of Clinical and Analytical Medicine. DOI: 10.4328/JCAM.2689.

32)    Meral GUNALDI, Melek ERKISI, Cigdem AFSAR, Vehbi ERCOLAK, Berna DUMAN, Semra PAYDAS, Ismail KARA, Berksoy SAHIN, Abdullah TULI, Ata SECILMIS. Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer. UHOD 2014; 24: 157-62.  

33)    Gunaldi M, Duman BB, Afsar CU, Paydas S, Erkisi M, Kara IO, Sahin B. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. J Oncol Pharm Pract. 2015 Jan 7. pii: 1078155214567162. [Epub ahead of print]

34)    Feryal Karaca, Çiğdem Usul Afşar, Özcan Öktem, Necat Almalı, Gökhan Yılmazer, Sıddık Keskin, Ali Murat Tatlı. Retrospective Evaluation of the Pancreatic Cancer Patients Who Received Chemoradiotherapy. Journal of Clinical and Analytical Medicine. DOI: 10.4328/JCAM.2975.

35)    Karaca F, Afsar CU, Gunaldi M, Erkurt E, Ercolak V, Sertdemir Y, Paydas S. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. Int J Clin Exp Med. 2015; 8(1): 876-82. eCollection 2015.

36)    Gunaldi M, Afsar CU, Okuturlar Y, Gedikbasi A, Kocoglu H, Kural A, Akarsu C, Gunduz U, Tiken EE. Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku J Exp Med 2015; 236(2): 97-102. doi: 10.1620/tjem.236.97.

37)    Ercolak V, Paydas S, Bagir E, Ergin M, Seydaoglu G, Celik H, Yavuz B, Tanriverdi K, Gunaldi M, Afsar CU, Duman BB. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma. Acta Haematol 2015; 134(4): 199-207.

38)    Günaldi M, Afsar CU, Duman BB, Kara IO, Tatli U, Sahin B. Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncol Lett 2015; 10(1): 439-42.

39)    Karabulut M, Gunaldi M, Alis H, Afsar CU, Karabulut S, Serilmez M, Akarsu C, Seyit H, Aykan NF. Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clin Transl Oncol 2016; 18(2): 160-71.

40)    Karabulut M, Alis H, Afsar CU, Karabulut S, Kocatas A, Oguz H, Aykan NF. Serum neural precursor cell-expressed, developmentally down regulated 9 (NEDD9) level may have a prognostic role in patients with gastric cancer. Biomed Pharmacother 2015; 73: 140-6. 

41)    Ercolak V, Sahin B, Gunaldi M, Duman BB, Afsar CU. Efficacy of paclitaxel in the treatment of Kaposi sarcoma. Eur Rev Med Pharmacol Sci 2015; 19(21): 4095-100.

42)    Karabulut S, Afsar CU, Karabulut M, Alış H, Kılıc L, Çikot M, Yasasever CT, Aykan NF. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. J Gastrointest Cancer 2016; 47(1): 47-54.

43)    Mehmet Karabulut, Halil Alis, Koray Bas, Senem Karabulut, Cigdem Usul Afsar, Hilal Oguz, Meral Gunaldi, Cevher Akarsu, Osman Kones, Nuri Faruk Aykan. Clinical Significance of Serum Cclaudin-1 and Claudin-7 Levels in Patients with Colorectal Cancer. Molecular and Clinical Oncology 2015; 3(6): 1255-67.

44)    Feryal Karaca, Cigdem Usul Afsar, Fatma Sert, Sebnem Izmir Guner, Vehbi Ercolak, Erkut Erkurt, Candas Tunali. Palliative Radiotherapy for Spinal Extramedullary Hematopoiesis in Thalassemia Major. International Blood Research & Reviews, 2015; 3(3): 124-9. 

45)    Feryal Karaca, Cigdem Usul Afsar, Meral Gunaldi, Ferhat Ozden, Ozcan Oktem, Fatma Sert, Necat Almalı, Gökhan Yılmazer, Ismail Sert. Effect of Adjuvant Chemoradiotherapy on Survival of Gastric Cancer Patients: Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. British Journal of Medicine & Medical Research 2015; 8(12): 1011-7. DOI: BJMMR.2015.532.

46)    Sebnem Izmir Guner, Mustafa Teoman Yanmaz, Ahmet Selvi, Cigdem Usul. Chemotherapy and Radiation Induced Pulmonary Dysfunction in Hodgkin Lymphoma Patients. Indian Journal of Hematology and Blood Transfusion 2016; 32(4): 431-6.

47)    Șebnem Izmir Güner, Mustafa Teoman Yanmaz, Ahmet Selvi, Cigdem Usul. The High Effect of Chemomobilization with High-Dose Etoposide + Granulocyte-Colony Stimulating Factor in Autologous Hematopoietic Peripheral Blood Stem Cell Transplantation: A Single Center Experience. Hematology Reports 2016; 8(1): 6319-22.

48)    Ummugul Uyeturk, Kaan Helvaci, Ayse Demirci, Ozlem Uysal Sonmez, Ibrahim Turker, Cigdem Usul Afsar, Burcin Budakoglu, Ulku Yalcintas Arslan, Omur Berna Oksuzoglu, Nurullah Zengin. Clinical outcomes and prognostic factors of adult’s Ewing sarcoma family of tumors: single center experience. Contemporary Oncology/Wspólczesna 2016 Jan DOI (digital object identifier): 10.5114/wo.2016.58487.

49)    Mehmet Karabulut, Halil Alış, Meral Günaldı, Çiğdem Usul Afşar, Senem Karabulut, Osman Kones, Hakan Seyit, Murat Serilmez, Nuri Faruk Aykan. Clinical significance of serum hepatocyte growth factor (HGF) and its receptor cmet levels in colorectal cancer patients. Acta Medica Mediterranea 2016, 32: 179-87.

50)    Karabulut S, Afsar CU, Karabulut M, Alis H, Bozkurt MA, Aydogan F, Serilmez M, Tas F. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma. BBA Clin 2016; 6: 138-142.

51)    Karabulut S, Usul Afsar C, Karabulut M, Alis H, Erturk K, Karaman S, Kones O, Bilgin E, Tas F. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy. J BUON 2016; 21(4): 895-902.

52)    Senem Karabulut, Cigdem Usul Afsar, Mehmet Karabulut, Leyla Kilic, Halil Alis, Osman Kones, Elif Bilgin, Nuri Faruk Aykan. Clinical significance of serum interleukin-17 levels in colorectal cancer patients. J BUON 2016; 21(5): 1137-45.

53)    Senem Karabulut, Cigdem Usul Afsar, Mehmet Karabulut, Halil Alis, Sinan Binboga, Irem Oner Ozkara, Feryal Karaca, Elif Bilgin, Faruk Tas.  Circulating macrophage inflammatory protein-1 alpha (MIP1-) as a potential biomarker for the diagnosis of patients with pancreatic adenocarcinoma. Acta Medica Mediterranea 2016, 32: 1035-40.

54)    Arslan E, Aral H, Aksoy T, Afşar ÇU, Karabulut S, Trabulus FDC, Gürsu RU, Çermik TF. Comparison of serum NEDD-9, CA 15-3, and CEA levels and PET metabolic parameters in breast cancer patients with 18 F-FDG PET / CT. Rev Assoc Med Bras (1992) 2020; 66(5): 673-9.

55)    Yardimci AH, Sel I, Bektas CT, Yarikkaya E, Dursun N, Bektas H, Afsar CU, Gursu RU, Yardimci VH, Ertas E, Kilickesmez O. Computed tomography texture analysis in patients with gastric cancer: a quantitative imaging biomarker for preoperative evaluation before neoadjuvant chemotherapy treatment. Jpn J Radiol 2020; 38(6): 553-60.
56)    Uysal P, Afsar CU, Sozer V, Inanc B, Agaoglu F, Gural Z, Fazlıoglu NY, Cuhadaroglu C, Uzun H. Evaluation of the relationship between serum ghrelin levels and cancer cachexia in patients with locally advanced nonsmall-cell lung cancer treated with chemoradiotherapy. J Cancer Res Ther 2020; 16(4): 855-9. doi: 10.4103/jcrt.JCRT_10_19.

57)    Yardımcı AH, Koçak B, Turan Bektaş C, Sel İ, Yarıkkaya E, Dursun N, Bektaş H, Usul Afşar Ç, Gürsu RU, Kılıçkesmez Ö. Tubular gastric adenocarcinoma: machine learning-based CT texture analysis for predicting lymphovascular and perineural invasion. Diagn Interv Radiol 2020; 26(6): 515-22. doi: 10.5152/dir.2020.19507.

58)    Karabulut S, Dogan I, Usul Afsar C, Karabulut M, Karaman S, Ferhatoglu F, Tastekin D. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? A Retrospective Multicenter Study. J Oncol Pharm Pract 2020 Sep 22:1078155220959427. doi: 10.1177/1078155220959427. Online ahead of print.

59)    Karabulut M, Afsar CU, Serilmez M, Karabulut S. Circulating annexin A2 as a biomarker in patients with pancreatic cancer. J Cancer Res Ther 2020; 16(Supplement): S110-S115.

60)    Yardımcı AH, Koçak B, Turan Bektaş C, Sel İ, Yarıkkaya E, Dursun N, Bektaş H, Usul Afşar Ç, Gürsu RU, Kılıçkesmez Ö. Tubular gastric adenocarcinoma: machine learning-based CT texture analysis for predicting lymphovascular and perineural invasion. Diagn Interv Radiol 2020; 26(6): 515-522

B. Papers presented at international scientific meetings and published in proceedings books
1) Selen Yurdakul, Cigdem Usul Afsar, Muzeyyen Beydogan, Mehmet Ucucu, Mecdi Erguney, Mustafa Kemal Arslantas. A young patient who had ventricular tachycardia after an sports activity: case report. Journal of Electrocardiology.  Volume 40, Issue 4, Supplement, Pages A2-A6, S1-S82 (July 2007) PAGE S28.
2) MERAL Günaldı, ÇİĞDEM PROCEDURE Afşar, YILDIZ Okuturlar, Asuman Gedikbaşı, ALEV Rule, Umut Day Time (2015). Can Heat Shock Protein 70 be a Target Therapy in Breast Cancer? International Symposium on Advances in Predictive and Personalized Medicine (Poster) (Control No: 1496317
3) Çiğdem Usul Afşar, Meral Günaldı, Feryal Karaca, İsmail Oğuz Kara, Berksoy Şahin, Berna Bozkurt Duman, Melek Köksal Erkişi, Semra Paydaş (2015). The effect of platinum and docetaxel based chemoradiotherapy on survival in locally advanced unresectable non-small cell lung cancer patients. ASCO 2015 (Poster) (Control No: 1496257)
4) Meral Günaldı, Melek Köksal Erkişi, Çiğdem Usul Afşar, Vehbi Erçolak, Semra Paydaş, İsmail Oğuz Kara, Berksoy Şahin, Ümran Güleç Küçükgöz, Mehmet Ata Seçilmiş. The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisims in Turkish breast cancer patients receiving tamoxifen treatment. ASCO 2014 (Poster) (Control No: 1496547)
5) Meral Günaldı, İsmail Oğuz Kara, Çiğdem Usul Afşar, Berna Bozkurt Duman (2012). Sorafenib in the treatment of metastatic paraganglioma: A case report. ASCO (Poster) (Control No: 1496008)
6) Berna Bozkurt Duman, Meral Günaldı, Burçak Evren Taşdoğan, Çiğdem Usul Afşar, Semra Paydaş, Yüksel Gümürdülü (2013). Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer. ASCO 2013 (Poster) (Control No: 1496046)
7) Çiğdem Usul Afşar, Berksoy Şahin, Deya Gümürdülü, Emine Kılıç Bağır, Refik Burgut, Melek Köksal Erkişi, İsmail Oğuz Kara, Meral Günaldı, Vehbi Erçolak (2014). The evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGF2), phosphatidylinositol 3 phosphate kinase (IP3K) expression and Their Clinical, Prognostic Significance in Early and Advanced Stage of Squamous Cell Carcinoma of The Lung. ESMO 2014 (Poster) (Control No: 1496136)
8) Çiğdem Usul Afşar, Meral Günaldı, Yıldız Okuturlar, Asuman Gedikbası, Alev Kural (2015). Paraoxonase and Arylesterase Activities in Patients with Coloractal Cancer. International Symposium on Advances in Predictive and Personalized Medicine (Poster) (Control No: 1496287)
9) Karabulut S, Afsar CU, Karabulut M, Alis H, Bilgin E, Tas F. Circulating macrophage inflammatory protein-1 alpha as a potential biomarker for the diagnosis in patients with pancreatic adenocarcinoma. 4th Mediterranean Multidisciplinary Oncology Forum (MMOF) 2015
10) Karabulut S, Afsar CU, Karabulut M, Alis H, Dural AC, Celebi K, Bilgin E, Tas F. Circulating annexin A2 as a biomarker in patients with pancreatic adenocarcinoma. 4th Mediterranean Multidisciplinary Oncology Forum (MMOF) 2015
11) Karabulut S, Afsar CU, Karabulut M, Alis H, Gümüsoglu AY, Celebi K, Bilgin E, Tas F. Elevated serum levels of caveolin-1 in patients with pancreatic adenocarcinoma. 4th Mediterranean Multidisciplinary Oncology Forum (MMOF) 2015
12) Karabulut S, Afsar CU, Karabulut M, Alis H, Bozkurt MA, Aydogan F, Bilgin E, Tas F. Clinical significance of serum omentin levels in patients with pancreatic adenocarcinoma. 4th Mediterranean Multidisciplinary Oncology Forum (MMOF) 2015
13) Cigdem Usul Afsar, Mehmet Karabulut, Senem Karabulut, Savas Tuna, Halil Alis, Murat Gonenc, Nergiz Dagoglu, Elif Bilgin, Faruk Tas. Circulating interleukin-18 (IL-18) as a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. J Clin Oncol 34, 2016 (suppl; abstr e15678). ASCO 2016 Abstract No: e15678
14) Senem Karabulut, Cigdem Usul Afsar, Vildan Yasasever, Mehmet Karabulut, Kayhan Erturk, Halil Alis, Meral Gunaldi, Kıvanc Derya Peker, Nergiz Dagoglu, Faruk Tas. Diagnostic and prognostic roles of serum interleukin-32 (IL-32) levels in patients with pancreatic adenocarcinoma. J Clin Oncol 34, 2016 (suppl; abstr e15680) ASCO 2016 Abstract No: e15680
15) A. Koro, H. Aral, R. U. Gursu, D. C. Trabulus, M. A. Nazli, C.U. Afsar, D. Karacetin, M. Usta. The blood neutrophil/lymphocyte ratio in breast cancer. FEBS 2016; 283 (Suppl 1): page 256.